Table 3.

Postoperative outcomes and complications (90 d) for 103 patients undergoing total pancreatectomy

Variable	Overall (n = 103)	PDAC (n = 42)	IPMN (n = 40)	LTP (n = 24)
Cardiac	10 (9.7%)	5 (11.9%)	3 (7.5%)	1 (4.2%)
Pulmonary	15 (14.6%)	7 (16.7%)	6 (15%)	5 (20.8%)
Renal insufficiency	8 (7.8%)	3 (7.1%)	6 (15%)	4 (16.7%)
Hepatic insufficiency	3 (2.4%)	1 (2.4%)	3 (7.5%)	2 (8.3%)
Major glycemic event	6 (5.8%)	3 (7.1%)	2 (5%)	1 (4.2%)
Post-pancreatectomy hemorrhage	5 (4.9%)	0 (0.0%)	4 (10%)	4 (16.7%)
A	2 (1.9%)	0	2 (5%)	2 (8.3%)
B	1 (0.8%)	0	0	1 (4.2%)
C	2 (1.9%)	0	2 (5%)	1 (4.2%)
Delayed gastric emptying	14 (13.6%)	5 (11.9%)	5 (12.5%)	2 (8.3%)
A	4 (4.9%)	2 (4.8%)	2 (5%)	0
B	5 (4.9%)	2 (4.8%)	1 (2.5%)	1 (4.2%)
C	5 (4.9%)	1 (2.4%)	2 (5%)	1 (4.2%)
Wound infection	11 (10.7%)	5 (11.9%)	2 (5%)	2 (8.3%)
Intra-abdominal abscess	14 (13.6%)	2 (4.8%)	8 (20%)	4 (16.7%)
Biliary fistula	2 (1.9%)	0	1 (2.5%)	0
Mesenteric/portal vein thrombosis	5 (4.9%)	2 (4.8%)	2 (5%)	1 (4.2%)
Reoperation	7 (6.8%)	2 (4.8%)	2 (5%)	2 (8.3%)
Patients intensive care stay	64 (62.1%)	24 (57.1%)	30 (75%)	10 (41.7%)
Median intensive care stay, d1 (range)	2 (1-59)	2 (1-12)	2 (1-59)	2 (1-33)
Overall morbidity	66 (64.1%)	27 (64.3%)	25 (62.5%)	10 (41.7%)
Major (III-V)	33 (32%)	13 (31%)	13 (32.5%)	5 (20.8%)
IIIa	14 (13.6%)	5 (11.9%)	6 (15%)	0
IIIb	3 (2.9%)	2 (4.8%)	0	0
IVa	4 (4.9%)	1 (2.4%)	2 (5%)	2 (8.3%)
IVb	5 (4.9%)	2 (4.8%)	1 (2.5%)	2 (8.3%)
V	7 (6.8%)	3 (7.1%)	4 (10%)	1 (4.2%)
Length of stay, d1 (range)	9 (3%-71%)	9 (3%-71%)	10 (4%-67%)	8 (4%-52%)
Readmission	26 (25.2%)	12 (28.6%)	8 (20%)	3 (12.5%)

¹Values are median (range), values in parenthesis are percentages unless otherwise indicated. IPMN: Intraductal papillary mucinous neoplasm; LTP: Laparoscopic total pancreatectomy; PDAC: Pancreatic ductal adenocarcinoma.